Vol 2 Issue 2

CELL AND GENE THERAPY INSIGHTS

February 2016 Issue

Vol 2 Issue 2

Download PDF

Featuring

Issue Spotlight: The Cell & Gene Therapy Manufacturing Pathway: Part 2
Other articles

SPOTLIGHT

The Cell & Gene Therapy Manufacturing Pathway: Part 2
Greg Russotti
Guest Editor:
Greg Russotti, Vice President, Technical Operations at Celgene Corporation

Expert Insight

An Industry Perspective on the Clinical Preparation of Cell Therapies

An Industry Perspective on the Clinical Preparation of Cell Therapies

Brian Murphy
6 July 2016
Read
Overcoming the Key Challenges in Delivering Cell and Gene Therapies to Patients: A View from the Front Line

Overcoming the Key Challenges in Delivering Cell and Gene Therapies to Patients: A View from the Front Line

Isabelle Riviere
6 July 2016
Read
Cell & gene therapies and the evolving role of personalized medicine

Cell & gene therapies and the evolving role of personalized medicine

Damian Marshall, Michaela Sharpe, Stephen Ward
6 July 2016
Read
Industry 4.0: a vision for personalized medicine supply chains?

Industry 4.0: a vision for personalized medicine supply chains?

Juergen Branke, Suzanne S Farid, Nilay Shah
6 July 2016
Read

Innovator Insight

Cell and Gene Therapies in Transit: Caution – Hazards Ahead

Cell and Gene Therapies in Transit: Caution – Hazards Ahead

Kevin O’Donnell
2 November 2016
Read
Cell Therapy: Bridging the Gap from Production to Patients

Cell Therapy: Bridging the Gap from Production to Patients

Eric Kunkel
16 August 2016
Read

Interview

Visualizing the cell and gene therapy supply chain of the future

Visualizing the cell and gene therapy supply chain of the future

Phil Vanek
6 July 2016
Read

Expert Roundtable Video

Visualizing the cell and gene therapy supply chain of the future

Visualizing the cell and gene therapy supply chain of the future

6 July 2016
Watch

Commercial Insights

The Integration of Manufacturing and Delivery into Healthcare Systems

The Integration of Manufacturing and Delivery into Healthcare Systems

Chris Mason, Elisa Manzotti
6 July 2016
Read

Review

Key considerations of cell and gene therapy cold chain logistics

Key considerations of cell and gene therapy cold chain logistics

F Meacle, J Salkin, M Brice et al.
6 July 2016
Read

Journal articles

Editorial

Implications of non-coding RNA on Cystic Fibrosis: new therapeutic avenues

Implications of non-coding RNA on Cystic Fibrosis: new therapeutic avenues

Paul McKiernan, Catherine Greene
6 July 2016
Read

Research Article

Successful ex vivo expansion of pro-angiogenic cells from one single primitive HSC

Successful ex vivo expansion of pro-angiogenic cells from one single primitive HSC

A Oikawa, G Mangialardi, J Richards et al.
6 July 2016
Read

Expert Insight

Progressing towards a cure for deafness through gene therapy

Progressing towards a cure for deafness through gene therapy

Patrick Atkinson, Madeline Nicholson, Rachael Richardson
6 July 2016
Read

Innovator Insight

Cell & Gene Therapy, and Regenerative Medicine – Different Definitions

Cell & Gene Therapy, and Regenerative Medicine – Different Definitions

Chris Mason, Elisa Manzotti, Emily Culme-Seymour
6 July 2016
Read

Interview

Visualizing the cell and gene therapy supply chain of the future

Visualizing the cell and gene therapy supply chain of the future

Phil Vanek
20 July 2016
Read

Commercial Insights

Cell & Gene Therapy Commercial Insight – May 2016

Cell & Gene Therapy Commercial Insight – May 2016

6 July 2016
Read
Clinical Trial Insight: Cell and Gene therapy Q2

Clinical Trial Insight: Cell and Gene therapy Q2

Alexey Bersenev
6 July 2016
Read
Commercial Insight – January 2016

Commercial Insight – January 2016

17 February 2016
Read

Review

Holoclar: first of its kind in more ways than one

Holoclar: first of its kind in more ways than one

G Milazzo, D Ardigo, M Toschi et al.
6 July 2016
Read